Briefly, a group of 498 patients with primary prostate adenocarcinomas were classified into “Low PKCα” or “High PKCα” mRNA expression levels according to the StepMiner one-step algorithm, establishing 134 tumors and 75 tumors in each category, respectively (Fig. 7A). The gene discussed is PRKCA; the disease is prostate adenocarcinoma.